FCMI
Foresite Capital Management I Portfolio holdings
AUM
$21.4M
This Quarter Return
+12.78%
1 Year Return
-80.48%
3 Year Return
-40.72%
5 Year Return
–
10 Year Return
–
AUM
$190M
AUM Growth
+$190M
(-46%)
Cap. Flow
-$212M
Cap. Flow
% of AUM
-111.45%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
EPZM
Epizyme, Inc
EPZM
|
$543K |
Top Sells
| 1 |
10x Genomics
TXG
|
$212M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
10x Genomics
TXG
$1.74B
| $177M | 93.12% | 1,250,000 -1,500,000 | -55% | -$212M |
|
2
Novavax
NVAX
$1.21B
| $7.45M | 3.92% | 66,810 | – | – |
|
|
EPZM
3
DELISTED
Epizyme, Inc
EPZM
| $3.19M | 1.68% | 293,759 +50,000 | +21% | +$543K |
|
|
XLRN
4
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.44M | 1.29% | 19,100 | – | – |
|